Adjuvant and neoadjuvant therapy in prostate cancer

被引：18

作者：

Chay, C ^{[1
]}

Smith, DC ^{[1
]}

机构：

[1] Univ Michigan, Sch Med, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI USA

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 01期

关键词：

D O I：

10.1053/sonc.2001.20744

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3 / 12

页数：10

共 44 条

[1]

Adib RS, 1997, BRIT J UROL, V79, P235

[2] Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer [J].

Albertsen, PC ;

Hanley, JA ;

Gleason, DF ;

Barry, MJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11) :975-980

[3]

Andriole GL, 1997, EUR UROL, V32, P65

[4]

[Anonymous], 1992, Lancet, V339, P1

[5] POSTOPERATIVE RADIOTHERAPY FOR PATIENTS WITH CARCINOMA OF THE PROSTATE UNDERGOING RADICAL PROSTATECTOMY WITH POSITIVE SURGICAL MARGINS, SEMINAL-VESICLE INVOLVEMENT AND OR PENETRATION THROUGH THE CAPSULE [J].

ANSCHER, MS ;

PROSNITZ, LR .

JOURNAL OF UROLOGY, 1987, 138 (06) :1407-1412

[6] MULTIVARIATE-ANALYSIS OF FACTORS PREDICTING LOCAL RELAPSE AFTER RADICAL PROSTATECTOMY - POSSIBLE INDICATIONS FOR POSTOPERATIVE RADIOTHERAPY [J].

ANSCHER, MS ;

PROSNITZ, LR .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (04) :941-947

[7] Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin [J].

Bolla, M ;

Gonzalez, D ;

Warde, P ;

Dubois, JB ;

Mirimanoff, RO ;

Storme, G ;

Bernier, J ;

Kuten, A ;

Sternberg, C ;

Gil, T ;

Collette, L ;

Pierart, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (05) :295-300

[8]

Byar D P, 1988, NCI Monogr, P165

[9]

BYAR DP, 1973, CANCER, V32, P1126, DOI 10.1002/1097-0142(197311)32:5<1126::AID-CNCR2820320518>3.0.CO

[10]

2-C

← 1 2 3 4 5 →